FDAFDA recall D-0871-2026 · Sep 30, 2026
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company: Clear Eyes Redness Relief recall
Recall found
Answer
Yes, Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with Hang Tag, 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15 is recalled as of Sep 30, 2026. On Sep 30, 2026, FDA announced recall D-0871-2026. What to do: follow the official FDA notice. Last checked Nov 17, 2026, 1:52 PM EST.
Product
Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with Hang Tag, 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15
Reason for recall
Lack of Assurance of Sterility
What to do
FDA enforcement reports don't include consumer instructions. Check the codes below against your packaging. If this is a medicine or device you use, talk to your pharmacist or doctor before you stop or change anything, and contact the company or FDA for what to do with the product.
| Lot, UPC, model, or component | Lot #: RL25G04, Exp. Date 07/2027; RL2H02, Exp. Date 08/2027 |
|---|---|
| Distribution | Nationwide in the USA. |
| Recall date | Sep 30, 2026 |
| Class | Class II |
| Agency ID | D-0871-2026 |
| Official notice | U.S. Food and Drug Administration (FDA) enforcement report |
| Data as of, last checked | Nov 17, 2026, 1:52 PM EST |
Recall details
- FDA classification
- Class II: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
- Status
- Ongoing
- Codes, lots and dates
- Lot #: RL25G04, Exp. Date 07/2027; RL2H02, Exp. Date 08/2027.
- Distribution
- Nationwide in the USA.
- Recalling firm
- Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, Tarrytown, NY
- Voluntary or mandated
- Voluntary: Firm initiated
- Recall started
- 2026-09-15
Source: openFDA enforcement record D-0871-2026 · search recall number D-0871-2026 in FDA's Enforcement Report.
Copied from the agency record without changes. Data as of Nov 17, 2026, 1:52 PM EST. The agency notice is the final word.
Questions
Can I get a refund?
Only if the official notice says so. Follow the remedy on this page and the FDA notice for D-0871-2026. ConsumerSun does not issue refunds.
How do I know if mine is affected?
Compare Lot #: RL25G04, Exp. Date 07/2027; RL2H02, Exp. Date 08/2027 with what you own, along with the product name and the recall date. The official notice is the final list.
Where is the official notice?
This page links to the FDA notice for D-0871-2026. That notice is the final word. ConsumerSun copies the agency record and does not replace it.
Related recalls
- Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company: Clear Eyes Redness Relief recall
- bioQuad Life Sciences: OsteoDenx capsules
- Medline: Beds, Rails, Mattresses, and accessories
- Game Changer Products, LLC: 10 Day Forecast Capsules 3200mg
- Eros Apothecary: Honey Dietary Supplement
- Henry Schein Inc.: Generic Name: Perma Sharp Sutures recall
